Other News
1:44 PM Dec 06, 2018
New Therapeutic Targets and Biomarker...
12:33 PM Dec 06, 2018
Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
11:58 AM Dec 13, 2018
U.S., Chinese academies planning meeting to set strict germline gene editing standards
The U.S. National Academy of Sciences, U.S. National Academy of Medicine and Chinese Academy of Sciences...
10:37 AM Dec 13, 2018
Biohaven nets $125M ahead of NDA submissions
Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHNV) raised $125 million late Wednesday through the sale...
9:47 AM Dec 13, 2018
Junshi IPO on deck in Hong Kong as WuXi AppTec shares debut
Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in their first day of trading...
9:00 AM Dec 13, 2018
Mission Bio raises $30M series B to expand Tapestri’s reach
Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an...
5:04 AM Dec 13, 2018
Government shutdown could hobble FDA
Political stalemate in Washington is raising the possibility of a partial government shutdown that could...
5:42 PM Dec 12, 2018
Management tracks: Tamura reclaims CEO role at Sosei
Sosei Group Corp. (Tokyo:4565) said Peter Bains will step down as president and CEO and resign as director...
4:57 PM Dec 12, 2018
BayHelix launches gene-editing task force
Following Chinese researcher Jiankui He's claims he used CRISPR to genetically modify two human embryos,...
4:50 PM Dec 12, 2018
Checkmate raises $22M as Krieg hands off CEO role
Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) said Wednesday it completed a $22 million extension of...
4:41 PM Dec 12, 2018
Contingency planning for U.K. biopharmas to continue after May survives vote
The U.K. life sciences sector avoided further turmoil after a confidence vote in the Conservative party...
4:23 PM Dec 12, 2018
Allen Institute's immunology division launches with $125M, Lilly vet and five partners
The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of...
3:31 PM Dec 12, 2018
Repurposing hypertension drugs to block cytokine release syndrome
Johns Hopkins University School of Medicine researchers showed that hypertension drug Demser metyrosine...
3:31 PM Dec 12, 2018
Tremfya superior to Cosentyx in head-to-head Phase III trial
Janssen Biotech Inc. said Tremfya guselkumab met the primary endpoint of improving PASI 90 response rate...
11:31 AM Dec 12, 2018
Neurocrine down on Phase IIb Tourette syndrome miss
Neurocrine Biosciences Inc. (NASDAQ:NBIX) lost $11.93 (14%) to $73.83 on Wednesday after it said...
10:41 AM Dec 12, 2018
Ra raises $130M on heels of Phase II myasthenia gravis readout
Ra Pharmaceuticals Inc. (NASDAQ:RARX) raised $130 million late Tuesday through the sale of 8.4 million...
10:27 AM Dec 12, 2018
NASH company Akero raises $70M, plans Phase IIa trial
Akero Therapeutics Inc. (San Francisco, Calif.) raised $70 million in a series B round to move non-...
3:30 AM Dec 12, 2018
Lilly, AC Immune to develop tau inhibitors
Eli Lilly and Co. (NYSE:LLY) partnered with AC Immune S.A. (NASDAQ:ACIU) to develop the biotech's pipeline...
4:18 PM Dec 11, 2018
New FDA guidance could spur biomarker-guided clinical trials
FDA released draft guidance on Tuesday providing an evidentiary framework for biomarker qualification,...
4:05 PM Dec 11, 2018
Management tracks: Merck creates new commercial roles to follow Schechter's exit
Merck & Co. Inc. (NYSE:MRK) said President of Global Human Health Adam Schechter will step down at the...
3:52 PM Dec 11, 2018
Anti-CD47 gel prevents cancer recurrence after surgery
ZenCapsule Inc. (Los Angeles, Calif.) is developing a localized sprayable gel similar to an anti-CD47...
3:23 PM Dec 11, 2018
Clock ticking for input on emerging biotech for export controls
Eight days remain for the biotech industry to provide input on how to define emerging technologies as the...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.